hesperetin has been researched along with Glial Cell Tumors in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arasoglu, T; Derman, S; Duranoglu, D; Erdemir, A; Ersoz, M; Mansuroglu, B; Uzunoglu, D | 1 |
| Abbott, NJ; Dobbie, MS; Kuhnle, G; Proteggente, AR; Rice-Evans, C; Youdim, KA | 1 |
2 other study(ies) available for hesperetin and Glial Cell Tumors
| Article | Year |
|---|---|
Comparative evaluation of hesperetin loaded nanoparticles for anticancer activity against C6 glioma cancer cells.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Carriers; Glioma; Glutathione; Hesperidin; Humans; Malondialdehyde; Nanoparticles; Oxidative Stress; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Superoxide Dismutase | 2019 |
Interaction between flavonoids and the blood-brain barrier: in vitro studies.
Topics: Animals; Anthocyanins; Blood-Brain Barrier; Brain; Cell Line; Chromatography, High Pressure Liquid; Coculture Techniques; Endothelium, Vascular; Flavanones; Flavonoids; Glioma; Glucuronides; Hesperidin; Mass Spectrometry; Mice; Microcirculation; Rats | 2003 |